Diseases of the salivary glands in infants and adolescents by Ellies, Maik & Laskawi, Rainer
REVIEW Open Access





Background: Diseases of the salivary glands are rare in infants and children (with the exception of diseases such
as parotitis epidemica and cytomegaly) and the therapeutic regimen differs from that in adults. It is therefore all
the more important to gain exact and extensive insight into general and special aspects of pathological changes
of the salivary glands in these age groups. Etiology and pathogenesis of these entities is still not yet fully known
for the age group in question so that general rules for treatment, based on clinical experience, cannot be given,
particularly in view of the small number of cases of the different diseases. Swellings of the salivary glands may be
caused by acute and chronic inflammatory processes, by autoimmune diseases, by duct translocation due to
sialolithiasis, and by tumors of varying dignity. Clinical examination and diagnosis has also to differentiate between
salivary gland cysts and inflammation or tumors.
Conclusion: Salivary gland diseases are rare in childhood and adolescence. Their pattern of incidence differs very
much from that of adults. Acute and chronic sialadenitis not responding to conservative treatment requires an
appropriate surgical approach. The rareness of salivary gland tumors is particularly true for the malignant parotid
tumors which are more frequent in juvenile patients, a fact that has to be considered in diagnosis and therapy.
Introduction
Diseases of the salivary glands are rare in infants and
children (with the exception of diseases such as parotitis
epidemica and cytomegaly) and the therapeutic regimen
differs from that in adults. It is therefore all the more
important to gain exact and extensive insight into gen-
eral and special aspects of pathological changes of the
salivary glands in these age groups. Previous studies
[1-3] have dealt with the clinical distribution pattern of
the various pathological entities in infants and older
children.
According to these studies, important pathologies in
these age groups are acute and chronic sialadenitis (with
special regard to chronic recurrent parotitis) and sec-
ondary inflammation associated with sialolithiasis
[2,4-6]. The etiology and pathogenesis of these entities
in young patients, however, are still not yet sufficiently
understood, so that therapeutic strategies based on
extensive clinical experience cannot be defined, particu-
larly in view of the small number of patients in the
relevant age groups. The acute forms of sialadenitis are
mainly caused by viral or bacterial infections. The pre-
dominant cause of parotid swelling in infancy is parotitis
epidemica [7]. This disease has its peak incidence
between the ages of 2 and 14 [8]. Acute inflammation of
the parotid gland, with evidence of Staphylococcus aur-
e u s ,i so f t e ns e e ni nn e o n a tes and in children with an
underlying systemic disease accompanied by fever, dehy-
dration, immunosuppression and general morbidity
[4,9]. Acute inflammation of the submandibular gland,
as opposed to that of the parotid is usually due to a
congenital anomaly of a salivary duct or an excretory
duct obstruction [4,10]. Reports on sialolithiasis in
infants and adolescents, however, are very scarce and
are mostly presented as rarities in clinical case reports
[6]. For chronic sialadenitis the predominant etiological
factors are secretion disorders and immunological reac-
tions [11]. The pathogenesis of chronic recurrent paroti-
tis has still not been completely elucidated and is, next
to mumps, the most frequent sialadenitis in infancy [12].
Neoplastic changes are very rare in children and ado-
lescents, compared to salivary gland inflammations [1].
Their annual incidence in all juvenile age groups is 1 to
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[13] salivary gland tumors make up 0.3% of all human
tumors, and less than 10% of all juvenile head and neck
tumors are located in the salivary glands [14]. Only 1%
of all head and neck tumors originate in the salivary
glands, regardless of patient age [15]. Not only makes
this low incidence the establishment of a generally
applicable therapeutic regimed i f f i c u l t ;t h i st a s ki sn o t
made easier by the circumstance that not more than 5%
of all salivary gland tumors are found in the age group
of up to 16 years [16]. As a consequence therapies very
often lean on experience gained in the last decades from
long-term studies for the treatment of adult patients.
Primary dysgenetic, and secondary, acquired salivary
gland cysts, and other malformations of the salivary
glands have to be distinguished early and without doubt
from specific benign and, above all, malignant lesions by
pathohistological examination [17].
Inflammatory Diseases of the salivary glands
Inflammatory salivary gland diseases, next to benign
neoplasms, are the most frequent causes of salivary
gland swelling in juvenile age [3]. The acute forms of
sialadenitis are bacterial and viral in origin. In child-
hood, the parotid gland is most frequently affected by
acute bacterial inflammation [2,4]. Predominant among
the bacterial pathogens are group A streptococci and
Staphylococcus aureus. This is supported by our own
findings [18]. Typical viral diseases are parotitis epide-
mica and cytomegaly. These clinical entities, because
they are well-known, were not included in our review.
Sialadenitis and sialolithiasis
In the extensive study of Zenk et al. [19] on 635
patients, sialolithiasis of the submandibular gland was
most frequent in patients between 31 and 55 years of
age, and only 6.1% of all patients with sialolithiasis of
the cephalic salivary glands were younger than 20 years.
Judging from the reports in the literature, sialolithiasis is
rarely observed in infants and adolescents [20,21]. In a
review covering a period of approximately 100 years
[22], there were only 21 documented cases of sialolithia-
sis of the submandibular gland in children between 3
weeks and 15 years of age. As in adults, the leading
symptom is a painful swelling of the afflicted gland that
abates postprandial. The literature describes sialolithiasis
in infants mostly in single case reports. The youngest
d o c u m e n t e dc a s ei nas i n g l ec a s er e p o r ti st h a to fa
two-year-old child [23]. Walsh and Robson [6] reported
the spontaneous passage of a submandibular salivary
duct calculus in a 9-year-old girl.
The children documented in our own study [18] con-
stitute a selected group of patients, since they presented
at our clinic for operative therapy in well-defined cases.
Concrements were located intraglandularly or found in
the proximal portion of the Wharton’sd u c t( s u b m a n -
dibular duct) in 66.7% of cases, and in 33.3% they were
localized outside the gland in the vicinity of the hilus
and of the distal portion of the excretory duct. Follow-
ing submandibulectomy or slitting of the Wharton’s
duct the patients were permanently free of symptoms.
In this context, Zenk et al. [24] describe a technique
with slitting of the Wharton’s duct in its entirety, identi-
fication and preservation of the lingual nerve and enoral
stone removal. Concrements located within the gland
are dealt with by excision of the submandibular gland.
We recommend removing sialoliths from the distal
portion of Wharton’s duct by slitting under perioperative
antibiotic cover. This procedure is also the first choice in
enoral proximally palpable stones, if the course of the
lingual nerve is taken into account. Our therapeutic con-
cept which is adapted to the location of the stone has
yielded satisfactory postoperative results and proved to
be effective in the treatment of sialolithiasis of the sub-
mandibular gland in childhood and adolescence.
We observed only one instance of sialolithiasis of the
parotid gland in a 4-year-old boy (2.2%) [18]. Zenk et al.
[24] found seven cases (1.1%) among their patients less
than 25 years. The same authors found amongst the
total of 635 patients studied, a solitary parotid gland
stone in a 4-year-old girl and a 2-year-old boy. Due to
the rarity of cases in this age group the therapy of paro-
tid sialolithiasis has to be adapted from that employed
for adults, in close cooperation with pediatric colleagues.
Acute sialadenitis of the submandibular gland without
evidence of concrement can be managed by temporary
drainage under antibiotic cover, similar to the therapy of
acute parotitis. In our patients, this was done in the
course of therapy for parotid abscess.
Chronic recurrent parotitis
Chronic recurrent parotitis is, next to mumps, the most
common inflammatory salivary gland disease in child-
hood and adolescence [8,11,12,25]. After sialolithiasis of
the submandibular gland, the group of patients with
chronic recurrent parotitis was the second largest in our
study. According to Grevers [26] this disease has a juve-
nile and an adult course of progression. Its pathogenesis
is not fully elucidated. There are conflicting opinions in
the literature as to a possible connection with congenital
[9,27], acquired or multifactorial inflammation-induced
stenosis and ectasia of the duct system [26], congenital
duct anomalies [27,28], and post-infectious factors [19].
In addition, the involvement of autoimmune processes
has been suggested [29]. Chronic sialectatic parotitis
(CSP) in infants and adolescents is a special entity [11]
whose pathogenesis may be associated with immuno-
pathological reactions of MALT (mucosa membrane
associated lymphoid tissue). This would support the
hypothesis [30] of an autoimmune etiology. According
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the third and sixth year of life. Accordingly, our analysis
shows a peak incidence in the group of 5- to 10-year-
old patients.
As mentioned above, the patients admitted to our
clinic in the period covered by our own studies [18]
were mainly those with frequent and extremely pro-
longed episodes of chronic recurrent parotitis with an
indication for surgery. Between 1966 and 2000, a num-
ber of invasive and surgical therapeutic concepts have
been applied in the treatment of this disease, interna-
tionally as well as in our department at the University of
Göttingen. Total parotidectomy was performed in 54.5%
of the cases and was without long-term complications.
In two patients, the disease had healed spontaneously by
the onset of puberty. Instillation of a fibrin-glue/genta-
mycin mixture into the Stenon’s duct was eventually
found to be unsuitable [31], and long-term results after
tympanic neurectomy were unsatisfactory [28]. Conse-
quently, both procedures were abandoned.
Based on our present knowledge, we recommend
symptomatic measures combined with the administra-
tion of antibiotics and analgesics for the initial treatment
of juvenile chronic recurrent parotitis. Sialendoscopical
removal of inspissated proteins in the stenon’sd u c tc a n
be helpful, too. We feel justified in making this recom-
mendation in view of this disease’s tendency to sponta-
neous healing before puberty [3]. Follow-up and control
examinations in short intervals are desirable in all
patients with successful initial conservative treatment to
detect early signs of recurrent parotitis by clinical and
ultrasound examinations. We stress the importance of
total parotidectomy when inflammatory episodes recur
frequently (with certain restrictions in prepubertal
patients here as well) as the only expedient option in
cases of drug resistance. All of our surgically treated
patients have remained free of complaints. The literature
reports lasting success rates of 80 to 100% [32,33]. Prior
to the operation, the parents must be thoroughly
informed about the purpose and technique of the proce-
dure, possibly also in the presence of the child. Specific
m e n t i o nm u s tb em a d eo ft h er i s ko ft e m p o r a r yf a c i a l
paresis and of the development of Frey’s syndrome.
Among our patients with chronic recurrent parotitis
we had two instances of temporary facial paresis follow-
ing parotidectomy [18]. This was already receding before
t h ep a t i e n t sw e r ed i s c h a r g e d from the hospital and was
no longer visible three months after surgery. This com-
plication is particularly not uncommon in patients with
frequent inflammatory episodes and consecutive fusion
between parenchyma and nerve fibers. We saw no
instance of persisting postoperative nerve injury or
symptomatic Frey’s syndrome following total extirpation
of the parotid gland due to chronic sialadenitis.
Tumors of the salivary glands
Due to the fact that tumors of the salivary glands in
childhood and adolescence are a rare disease, it is in our
opinion not very easy to make a comparison with a
similar adult population. On the one hand, it is not pos-
sible to get significant information especially due to the
high variety of different tumors. On the other hand, the
problem of a retrospective clinical investigation is some-
times a lack of specific information, which makes it
hard to determine a really similar adult population.
Lesions of the major cephalic salivary glands, with the
exception of mumps and cytomegaly, are unusual in
children and adolescents and may give rise to a number
of different tentative diagnoses. Since malignant salivary
gland tumors are relatively more frequent in young per-
son’s than in adults, a safe diagnosis has to be made
quickly and without delay. This is even more important
as according to Ussmüller et al. [34] about one half of
all juvenile salivary gland tumors may be malignant
tumors.
Benign Neoplasms
A c c o r d i n gt oas t u d yb yL u n ae ta l .[ 3 5 ]o nt u m o ri n c i -
dence in the salivary glands, based on data of 6 centers
comprising 9823 patients, 3.3% of all neoplasms, regardless
of their dignity, are found in persons younger than 16
years. Castro et al.[36] found among 2135 cases 38 young
patients between 5 and 16 years with salivary gland
tumors, corresponding to an incidence of only 1.8%.
Due to our own studies [37] there were 40 patients
with benign lesions, 79% of which were localized in the
parotid gland, with a predominance of pleomorphic ade-
nomas (60%) in the age range investigated. This is in
accordance with a number of other reports [14,38].
Luna et al. [35], too, state that pleomorphic adenomas
are the most frequent benign epithelial tumors in child-
hood. Other teams, however, saw a majority of non-
epithelial neoplasms, haemangioma and lymphangioma
(Fig. 1), in the group of benign growths [39]. In a study
of 782 cases examined with respect to histological classi-
fication, Ussmüller et al. [34] found a dominance of
non-epithelial tumors in the first years of life. In still
another study [40] the non-epithelial tumors were the
most frequent benign neoplasms in the parotid region
(50%) in newborns and infants. This agrees well with
our findings. We saw 66.6% of non-epithelial tumors
(haemangioma, haemangiolymphoma) in infants. Ener-
oth und Hjertman [41] found 75-85% of all benign
lesions in the parotid, and 10% in the submandibular
gland. This is very similar to our observations (parotid
gland: 92.5%, submandibular gland: 7.5%) [37].
The rarity of salivary gland tumors in young people
makes it impossible for just one ENT department to
gain solid experience in their diagnosis and therapy. It
should be the aim of reports on therapeutic experience
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tional otolaryngological scene with operation results.
Our particular interest was focused on pleomorphic ade-
noma, due to its high incidence clinically the most
important tumor for the development of surgical
approaches. In the early years covered by our report,
prior to introduction of lateral, respectively total, paroti-
dectomy, always with preparation of the parotid plexus,
we saw tumor recurrences in 80% of cases following
enucleation alone. This result resembles that of another
study [42] which reported an incidence of 20-45% of
recurrences after enucleation. According to Leverstein et
al.[43] most recurrences arose from inadequate opera-
tion techniques. Arnold [44] has nicknamed pleo-
morphic adenoma as a “wolf in sheep’ss k i n " :
Enucleation carries the risk of tumor cell transfer,
respectively incomplete tumor removal, since a large
percentage of pleomorphic adenomas are not completely
encapsulated or are enveloped only by a thin layer of
connective tissue.
The relatively high proportion of recurrences which
we observed despite correct operation techniques may
be explained by the fact that the majority of patients
presented at our clinic for second operations after pri-
mary surgery elsewhere. After introduction of operation
microscope-controlled techniques and after performance
of lateral parotidectomy for laterally localized adenomas
the frequency of recurrences was dramatically reduced
to 2% [45]. When using operation microscope-based
techniques at our clinic, recurrences were virtually
absent after primary operations. We therefore recom-
mend the following procedure for surgery of parotid
pleomorphic adenoma.
The therapy of pleomorphic adenoma consists of lat-
eral parotidectomy with en-bloc excision of the tumor
within the surrounding tissues, preserving facial nerve
integrity. This is the smallest operation and helps to
minimize the risk of recurrences [46]. The important
first preoperative diagnostic step in young patients is
sonographic examination of the parotid region. Fine-
needle aspiration biopsy, routinely used in adults for dif-
ferential diagnosis, is also applicable in children, and a
safe decision for further therapy is in most cases also
possible. For deep-lying tumors, total parotidectomy
with preservation of the facial nerve is the therapy of
choice. The majority of pleomorphic adenomas is loca-
lized in the lateral portion of the parotid gland [43,45].
McGurk et al. [45] found even 90% of all adenomas in
the superficial parotid lobe, situated laterally of the par-
otid plexus. In our retrospective study of operation
reports, however, we found a higher proportion of
tumors (47.6%) in the deep lobe of the parotid gland,
medially of the parotid plexus. The superficial part of
the parotid harbored 42.9% of all pleomorphic adeno-
mas [37].
Malignant Neoplasms
Although malignant salivary gland tumors are uncom-
mon in children and adolescents, clinical diagnosis has
to be made very carefully, since compared with adults
the proportion of malignancies among all neoplasms is
relatively high. In childhood 80-90% of all malignant
lesions of the salivary glands are made up by mucoepi-
dermoid carcinomas (Fig 2), adenoid-cystic carcinomas
and acinic cell carcinomas. The corresponding figure in
adults is only 45%. While Eneroth [47], in his study of
incidence and prognosis of 2632 patients with tumors of
the major and minor salivary glands, found an incidence
of 15-25% of malignant neoplasms for adults, many
teams reported a significantly higher relative proportion
in young patients. In the age range studied by us, 50%
Figure 1 Infant shows a haemangioma on the left side of the neck.
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mas and lymphangiomas are not included [36,48].
Schuller and McCabe [49] report a slighly higher inci-
dence of 57.1%.
In adults, 65-75% of the epithelial neoplasms are
benign in nature, but in children only between 50 and
60% [48,49]. Many publications agree that mucoepider-
moid carcinoma is the most abundant malignant salivary
gland tumor in young patients [14,38]. This is confirmed
by our own investigations [37]. Within the group of sali-
vary gland malignancies we found 33.3% of mucoepider-
moid carcinomas, followed in frequency by 25% each of
adenoid-cystic carcinomas and embryonic rhabdomyo-
sarcomas. The highest incidence of mucoepidermoid
carcinoma is found in the second decade of life, while
the tumor is rare in the first [50]. Determination of his-
tological subtypes yielded 3 low-grade (highly differen-
tiated) mucoepidermoid carcinomas (75%) that have a
high 5-year survival rate (more than 95%) according to
Chomette et al. [51]. This favorable prognosis was con-
firmed by the results of follow-up of patients with this
tumor who were treated at our clinic. One patient died
in the postoperative observation period from a high-
grade (low differentiation) mucoepidermoid carcinoma.
The characteristic and determining factor in the group
of adenoid-cystic carcinomas is their perivascular and
perineural tendency for infiltration [52] which makes
prognosis less favorable with a 5-year survival rate of
60% and a 10-year survival rate of 40% in all age groups
[53]. During a follow-up period of 25 years we did not
lose a single patient operated for this tumor.
In their survey of patients younger than 20 years,
Byers et al. [54] measured a 5-year survival rate of 50%
for patients with acinic cell carcinoma, including high-
grade carcinomas in the statistical evaluation. Data from
our clinic on this malignancy include only patients with
low-grade acinic cell carcinoma who had a 5-year survi-
val rate of 100%.
Embryonic rhabdomyosarcomas of the cephalic sali-
v a r yg l a n d sa r er a r e[ 5 5 ]a n dh a v eap o o rp r o g n o s i s
since the patients present in most cases with already far
advanced tumor invasion. Rogers et al. [56] were report-
ing on 9 patients between 1 and 13 years, 77.7% of
whom died 6 to 9 months after diagnosis. This is in
accordance with our experience with young patients
with an embryonic rhabdomyosarcoma of the parotid
gland. All 3 patients died within a few months after the
initial diagnosis. In the extended study of Castro et al.
[36] the 5- and 10-year survival rates for salivary malig-
nancies, with the exception of sarcomas, were 94,
respectively 95%.
Our surgical concept and our favorable long-term
results show that total or radical parotidectomy, some-
times including extended resection of neighbouring
structures, is the best therapy for malignant parotid
tumors in children, with relatively few complications
throughout the follow-up period [37]. No statement can
be given about the outcome of radiation therapy because
none of the patients in our investigation received it.
However, for the establishment of an individual concept
of oncological therapy (parotidectomy, neck dissection,
chemotherapy, radiotherapy), interdisciplinary coopera-
tion with the pediatrician is mandatory.
Figure 2 Mucoepidermoid carcinoma of the right parotid gland occurred in a young girl.
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Salivary gland diseases are rare in infants and children.
Acute and chronic sialadenitis not amenable to conser-
vative therapy requires surgical treatment. The clinical
course of chronic recurrent sialadenitis in children has a
great potential for spontaneous healing, but in a number
of cases it does not permit waiting for spontaneous heal-
ing until puberty but requires surgical intervention. As
these diseases are rarer in young people than in adults,
it is difficult to establish universally valid therapeutic
guidelines. Salivary gland tumors, rare in childhood and
adolescence, differ in their incidence and dignity
between juvenile and adult patients. This is particularly
true of parotid malignancies which are more frequent in
young persons. This fact has to be taken into account in
diagnosis and therapy. Long-term multicenter studies
for comparison of treatment strategies are needed in the
coming decades to guarantee further optimization of
tumor management on a profound clinical and scientific
basis, for the benefit of our young patients.
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